Quick Answer
TriSalus Life Sciences, Inc. reported Net Income of -$39.23 million for fiscal year 2025.
TriSalus Life Sciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$39.23M | -30.6% |
| 2024 | -$30.05M | +49.4% |
| 2023 | -$59.36M | -25.8% |
| 2022 | -$47.19M | -1089.8% |
| 2021 | $4.77M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$10.81M | -350.6% | -30.4% |
| June 30, 2025 | -$8.29M | -91.3% | +20.1% |
| March 31, 2025 | -$10.38M | +21.4% | -332.5% |
| September 30, 2024 | -$2.40M | -68.4% | +44.6% |
| June 30, 2024 | -$4.33M | +69.0% | +67.2% |
| March 31, 2024 | -$13.21M | -58.9% | -826.7% |
| September 30, 2023 | -$1.43M | +82.4% | +89.8% |
| June 30, 2023 | -$13.98M | -61.1% | -68.2% |
- TriSalus Life Sciences, Inc. showed a decrease of -30.6% in Net Income compared to the prior fiscal year.
- Over the 2021–2025 period, TriSalus Life Sciences, Inc.’s net income has declined by 922.8% (from $4.77 million to -$39.23 million).
- The most recent figure is from TriSalus Life Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: